These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Direct oral anticoagulants for treatment and prevention of venous thromboembolism in cancer patients. Song AB; Rosovsky RP; Connors JM; Al-Samkari H Vasc Health Risk Manag; 2019; 15():175-186. PubMed ID: 31417269 [TBL] [Abstract][Full Text] [Related]
7. Rivaroxaban for thromboprophylaxis among patients recently hospitalized for acute infectious diseases: a subgroup analysis of the MAGELLAN study. Cohoon KP; De Sanctis Y; Haskell L; McBane RD; Spiro TE J Thromb Haemost; 2018 Jul; 16(7):1278-1287. PubMed ID: 29753308 [TBL] [Abstract][Full Text] [Related]
8. Impact of anticoagulant choice on hospitalized bleeding risk when treating cancer-associated venous thromboembolism. Zakai NA; Walker RF; MacLehose RF; Adam TJ; Alonso A; Lutsey PL J Thromb Haemost; 2018 Dec; 16(12):2403-2412. PubMed ID: 30240508 [TBL] [Abstract][Full Text] [Related]
9. Parenteral anticoagulation in ambulatory patients with cancer. Akl EA; Kahale LA; Ballout RA; Barba M; Yosuico VE; van Doormaal FF; Middeldorp S; Bryant A; Schünemann H Cochrane Database Syst Rev; 2014 Dec; (12):CD006652. PubMed ID: 25491949 [TBL] [Abstract][Full Text] [Related]
11. Periprocedural interruption of anticoagulation in patients with cancer-associated venous thromboembolism: An analysis of thrombotic and bleeding outcomes. Shaw JR; Douketis J; Le Gal G; Carrier M J Thromb Haemost; 2019 Jul; 17(7):1171-1178. PubMed ID: 31038838 [TBL] [Abstract][Full Text] [Related]
12. Abnormal uterine bleeding in women receiving direct oral anticoagulants for the treatment of venous thromboembolism. Godin R; Marcoux V; Tagalakis V Vascul Pharmacol; 2017 Aug; 93-95():1-5. PubMed ID: 28479313 [TBL] [Abstract][Full Text] [Related]
13. Rivaroxaban for Preventing Venous Thromboembolism in High-Risk Ambulatory Patients with Cancer: Rationale and Design of the CASSINI Trial. Rationale and Design of the CASSINI Trial. Khorana AA; Vadhan-Raj S; Kuderer NM; Wun T; Liebman H; Soff G; Belani C; O'Reilly EM; McBane R; Eikelboom J; Damaraju CV; Beyers K; Dietrich F; Kakkar AK; Riess H; Peixoto RD; Lyman GH Thromb Haemost; 2017 Nov; 117(11):2135-2145. PubMed ID: 28933799 [TBL] [Abstract][Full Text] [Related]
14. Anticoagulation strategies for venous thromboembolism: moving towards a personalised approach. Black SA; Cohen AT Thromb Haemost; 2015 Oct; 114(4):660-9. PubMed ID: 26084864 [TBL] [Abstract][Full Text] [Related]
15. Primary venous thromboembolism prophylaxis in ambulatory cancer patients. Aikens GB; Rivey MP; Hansen CJ Ann Pharmacother; 2013 Feb; 47(2):198-209. PubMed ID: 23386067 [TBL] [Abstract][Full Text] [Related]
16. Prophylaxis and treatment of venous thromboembolism in patients with cancer: the Saudi clinical practice guideline. Al-Hameed F; Al-Dorzi HM; AlMomen A; Algahtani F; AlZahrani H; AlSaleh K; AlSheef M; Owaidah T; Alhazzani W; Neumann I; Wiercioch W; Brozek J; Schünemann H; Akl EA Ann Saudi Med; 2015; 35(2):95-106. PubMed ID: 26336014 [TBL] [Abstract][Full Text] [Related]
17. Personalized thromboprophylaxis using a risk score for the management of pregnancies with high risk of thrombosis: a prospective clinical study. Dargaud Y; Rugeri L; Fleury C; Battie C; Gaucherand P; Huissoud C; Rudigoz RC; Desmurs-Clavel H; Ninet J; Trzeciak MC J Thromb Haemost; 2017 May; 15(5):897-906. PubMed ID: 28231636 [TBL] [Abstract][Full Text] [Related]
18. Management of cancer-associated venous thromboembolism - a case-based practical approach. Voigtlaender M; Langer F Vasa; 2018 Feb; 47(2):77-89. PubMed ID: 29325495 [TBL] [Abstract][Full Text] [Related]
20. Direct oral anticoagulants in patients with venous thromboembolism and thrombophilia: a systematic review and meta-analysis. Elsebaie MAT; van Es N; Langston A; Büller HR; Gaddh M J Thromb Haemost; 2019 Apr; 17(4):645-656. PubMed ID: 30690830 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]